← Back to Search

Enteral Formula

Nutritional Formula for Tube Feeding

N/A
Waitlist Available
Led By Jean Chouinard, MD
Research Sponsored by Société des Produits Nestlé (SPN)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days
Awards & highlights

Study Summary

This trial will study how safe and effective a specialized nutritional formula is for adults needing tube feeding.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Nutritional adequacy (caloric goals)
Secondary outcome measures
Adverse events Adverse events
Daily stool description and frequency - Bristol stool scale
Frequency of abdominal distention
+5 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Enteral Nutrition (EN) FormulaExperimental Treatment1 Intervention
Enteral formula

Find a Location

Who is running the clinical trial?

Société des Produits Nestlé (SPN)Lead Sponsor
337 Previous Clinical Trials
62,562 Total Patients Enrolled
2 Trials studying Tube Feeding
50 Patients Enrolled for Tube Feeding
Bruyere Research InstituteOTHER
34 Previous Clinical Trials
2,024,216 Total Patients Enrolled
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.NETWORK
32 Previous Clinical Trials
1,910 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any unfilled slots left in this research endeavor?

"According to the data hosted on clinicaltrials.gov, this medical trial is not currently recruiting participants - it was posted on March 1st of 2023 and last edited nearly two months ago. However, there are 9 other trials actively enrolling patients at present."

Answered by AI
~1 spots leftby Apr 2025